Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
Would you consider anti-CD20 agents for treatment of multiple sclerosis in patients with history of breast cancer?
Related Questions
Do you send CSF or serum ACE levels in the workup of neurosarcoidosis?
What is your treatment approach to neurological Sjogrens disease with both peripheral neuropathy and transverse myelitis?
How frequently do you recommend ordering labs to monitor for side effects of disease-modifying therapies for multiple sclerosis?
What is your initial treatment paradigm for someone with both CNS and peripheral neurologic Sjogren’s?
Do you see a current or future clinical role of neurofilament light chain in the diagnosis or workup of multiple sclerosis?
How do you approach managing nausea and GI side effects when initiating methotrexate?
How do you distinguish between primary progressive MS versus relapsing remitting MS with superimposed relapses in a newly diagnosed patient that is naive to treatment?
What is your approach to DVT prophylaxis in patients who require IVIG but are at increased risk for thrombotic events?
Can you use a JAK inhibitor and Mavenclad in a patient with both multiple sclerosis and rheumatoid arthritis?
How do you use optical coherence tomography in the diagnosis and management of patients with multiple sclerosis and related diseases?
